Sign in
4

Changes in Ownership

Milestone Pharmaceuticals Inc. Filed Acc 0001415889-25-002265

Options or other derivatives

  • President and CEO acquired 666,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Oliveto Joseph President and CEO 2025-01-27 Grant or award · Employee Stock Option (right to buy) +399,600 399,600 D
Oliveto Joseph President and CEO 2025-01-27 Grant or award · Restricted Stock Unit +266,400 266,400 D
Loading xslF345X05/form4-01292025_040104.xml…